| NDC (N = 11) | FTD-GRN (N = 9) | FTD-MAPT (N = 13) |
---|---|---|---|
Demographics | Â | Â | Â |
Female, n (%) | F: 7/11 (63,6) | F: 5/8 (62,5) | F: 5/11 (45,5) |
 | T: 5/8 (62,5) | T: 5/9 (55,6) | T: 5/13 (38,5) |
Age, median (range) | F: 83 (60–91) | F: 65 (52–76) ‡ | F: 60 (49–75) ‡ |
 | T: 83 (60–91) | T: 65 (52–76) †| T: 60 (46–75) ‡ |
Clinical characteristics | Â | Â | Â |
Genetic mutation (n) | n/a | C105fs (1) | G272V (4) |
 |  | G24X (1) | P301L (8) |
 |  | G125X (1) | R406V (1) |
 |  | G300X (1) |  |
 |  | S82VfsX174 (4) |  |
 |  | C31LfsTer34 (1) |  |
Disease pathology (n) | NA | FÂ | T: | F |Â T: |
• Atypical Pick’s disease |  | – | – | 4 | 4 |
• Tau |  | – | – | 7 | 9 |
• TDP-type A |  | 8 | 8 | – | – |
• Undetermined |  | – | 1 | – | – |
ApoE profile (n) | FÂ | T: | FÂ | T: | FÂ | T: |
• 32 | – | – | 2 | 2 | 1 | 1 |
• 33 | 6 | 3 | 3 | 3 | 5 | 7 |
• 42 | – | – | – | – | – | – |
• 43 | 2 | 2 | – | – | 3 | 3 |
• 44 | 1 | 1 | – | – | 1 | 1 |
• Unknown | 2 | 2 | 3 | 4 | 1 | 1 |
Post-mortem determinants | Â | Â | Â |
Post-mortem delay, median (range) | F: 05:50 (03:35–08:00) | F: 05:00 (03:35–06:05) * | F: 05:23 (04:10–11:30) |
 | T: 05:54 (03:35–08:00) | T: 05:00 (03:35–06:05) | T: 05:35 (04:10–11:30) |
Cerebrospinal fluid pH, median (range) | F: 6.75 (6.26–7.20) | F: 6.36 (6.10–6.52) †| F: 6.46 (5.91–6.64) †|
 | T: 6.72 (6.26–7.20) | T: 6.36 (6.10–6.52) †| T: 6.46 (5.91–6.64) * |
Brain weight in grams, median (range) | F: 1188 (943–1590) | F: 954 (830–1242) * | F: 962 (652–1188) †|
 | T: 1130 (943–1590) | T: 954 (830–1242) * | T: 1011 (652–1188) * |
Braak score, median (range) | F: 1 (0–2) | n/a | n/a |
 | T: 2 (0–2) |  |  |